Computationally Designed ACE2 Decoy Receptor Binds SARS-CoV‑2 Spike (S) Protein with Tight Nanomolar Affinity
journal contributionposted on 24.08.2021, 15:35 authored by Brandon Havranek, Kui K. Chan, Austin Wu, Erik Procko, Shahidul M. Islam
Even with the availability of vaccines, therapeutic options for COVID-19 still remain highly desirable, especially in hospitalized patients with moderate or severe disease. Soluble ACE2 (sACE2) is a promising therapeutic candidate that neutralizes SARS CoV-2 infection by acting as a decoy. Using computational mutagenesis, we designed a number of sACE2 derivatives carrying three to four mutations. The top-predicted sACE2 decoy based on the in silico mutagenesis scan was subjected to molecular dynamics and free-energy calculations for further validation. After illuminating the mechanism of increased binding for our designed sACE2 derivative, the design was verified experimentally by flow cytometry and BLI-binding experiments. The computationally designed sACE2 decoy (ACE2-FFWF) bound the receptor-binding domain of SARS-CoV-2 tightly with low nanomolar affinity and ninefold affinity enhancement over the wild type. Furthermore, cell surface expression was slightly greater than wild-type ACE2, suggesting that the design is well-folded and stable. Having an arsenal of high-affinity sACE2 derivatives will help to buffer against the emergence of SARS CoV-2 variants. Here, we show that computational methods have become sufficiently accurate for the design of therapeutics for current and future viral pandemics.
Read the peer-reviewed publication
ninefold affinity enhancementlow nanomolar affinityfuture viral pandemicscell surface expressionbecome sufficiently accuratepromising therapeutic candidateaffinity sace2 derivativesace2 -< busing computational mutagenesisdesigned sace2 derivativeneutralizes sars covtherapeutic optionsmutagenesis scancomputational methodstype ace2soluble ace2verified experimentallyslightly greatersilico </severe diseasesars covmolecular dynamicsincreased bindinghospitalized patientsfour mutationsflow cytometryenergy calculationsbinding experimentsbinding domain2 variants2 tightly2 infection